Pharmaceutical company Iambic Therapeutics is seeking to raise up to $159.4 million through an initial public offering, and Nvidia is one of the company's shareholders. According to the documents, the company plans to issue 9.38 million shares at a price of 15 to 17 US dollars per share. Based on the upper limit of the issue price range and the issued shares listed in the document, the company's market value will be approximately US$805.8 million.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.